Compare CHE & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHE | BIRK |
|---|---|---|
| Founded | 1970 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | 8000 |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 5.6B |
| IPO Year | 1994 | 2023 |
| Metric | CHE | BIRK |
|---|---|---|
| Price | $522.24 | $33.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $501.50 | $61.43 |
| AVG Volume (30 Days) | 132.2K | ★ 2.9M |
| Earning Date | 04-23-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.97 | N/A |
| Revenue | ★ $2,529,978,000.00 | N/A |
| Revenue This Year | $6.56 | $13.71 |
| Revenue Next Year | $6.23 | $14.30 |
| P/E Ratio | $52.61 | ★ $17.48 |
| Revenue Growth | ★ 4.06 | N/A |
| 52 Week Low | $365.21 | $31.33 |
| 52 Week High | $557.00 | $50.73 |
| Indicator | CHE | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 35.98 |
| Support Level | $520.68 | $33.06 |
| Resistance Level | $553.35 | $37.29 |
| Average True Range (ATR) | 14.05 | 1.34 |
| MACD | -3.84 | -0.06 |
| Stochastic Oscillator | 45.83 | 4.01 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.